Skin testing to predict immune response to hepatitis B vaccine

Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people having unprotected sex.

AIDS care·2022

Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy.

ESMO open·2021

Measurement of the Jet Mass Distribution and Top Quark Mass in Hadronic Decays of Boosted Top Quarks in pp Collisions at sqrt[s]=13 TeV.

Physical review letters·2020

Constraints on the χ_{c1} versus χ_{c2} Polarizations in Proton-Proton Collisions at sqrt[s]=8 TeV.

Physical review letters·2020

Search for a Narrow Resonance Lighter than 200 GeV Decaying to a Pair of Muons in Proton-Proton Collisions at sqrt[s]=13 TeV.

Physical review letters·2020

Search for direct pair production of supersymmetric partners to the lepton in proton-proton collisions at .

The European physical journal. C, Particles and fields·2020

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against Francisella tularensis.

Infection and immunity·2026

A Stable Isopterin Mimic of a Potent Bacterial Stimulant of T Cells.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026

Morphometric Study of the Human Cadaveric Spleen: Dimensions, Shape Variations, and the Prevalence of Border Notches and Fissures.

Cureus·2026

Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice.

Vaccine: X·2026

Invasive pneumococcal disease by serotype 23B in an asplenic unvaccinated patient: A case report.

IDCases·2026

Psychological distress as a putative host-state determinant of cancer immunotherapy response.

Frontiers in immunology·2026

Related Experiment Videos

Skin testing to predict immune response to hepatitis B vaccine

Related Concept Videos

Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people having unprotected sex.

Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy.

Measurement of the Jet Mass Distribution and Top Quark Mass in Hadronic Decays of Boosted Top Quarks in pp Collisions at sqrt[s]=13 TeV.

Constraints on the χ_{c1} versus χ_{c2} Polarizations in Proton-Proton Collisions at sqrt[s]=8 TeV.

Search for a Narrow Resonance Lighter than 200 GeV Decaying to a Pair of Muons in Proton-Proton Collisions at sqrt[s]=13 TeV.

Search for direct pair production of supersymmetric partners to the lepton in proton-proton collisions at .

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against Francisella tularensis.

A Stable Isopterin Mimic of a Potent Bacterial Stimulant of T Cells.

Morphometric Study of the Human Cadaveric Spleen: Dimensions, Shape Variations, and the Prevalence of Border Notches and Fissures.

Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice.

Invasive pneumococcal disease by serotype 23B in an asplenic unvaccinated patient: A case report.

Psychological distress as a putative host-state determinant of cancer immunotherapy response.

Related Experiment Videos

Skin testing to predict immune response to hepatitis B vaccine

Related Concept Videos

Related Articles